Skip to main content

Table 1 Correlation of miR-155 expression with clinicopathological factors of ATC patients

From: MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1

ParametersPatientsmiR-155P
Total31  
Gender  0.942
 Male5 (16.1)3.46 ± 1.52 
 Female26 (83.9)3.15 ± 1.06 
Age (Y)  0.513
  ≥ 4516 (51.6)3.34 ± 1.18 
  < 4515 (48.4)3.10 ± 1.07 
Tumor size,cm  0.204
  ≥ 225 (80.6)3.36 ± 1.20 
  < 26 (19.4)2.71 ± 0.98 
Extrathyroidal invasion  0.033
 Yes24 (77.4)3.78 ± 1.24 
 No7 (22.6)1.47 ± 0.51 
Multicentricity  0.142
 Yes17 (54.8)3.41 ± 1.21 
 No14 (45.2)2.95 ± 1.01 
Cervical metastasis status  0.021
 N+22 (44.7)4.16 ± 1.38 
 N-9 (55.3)1.35 ± 0.47 
  1. Note: Values in parentheses represent percentages